Thermo Fisher Scientific (TMO) Restructuring Costs (2009 - 2026)

Thermo Fisher Scientific has reported Restructuring Costs for 18 years, with the latest figure at $98.0 million in Q2 2026.

• Restructuring Costs for Q2 2026 came in at $98.0 million, up 19.51% year-over-year; the trailing twelve-month figure through Jun 2026 was $328.0 million (down 27.59% YoY), and the FY2025 annual result was $362.0 million, down 4.49% from the prior year.
• Restructuring Costs advanced to $98.0 million in Q2 2026, from $49.0 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $228.0 million in Q4 2024 and troughed at $2.0 million in Q2 2022.
• A 5-year average of $81.1 million and a median of $78.5 million in 2023 frame the typical range for Restructuring Costs.
• The widest annual swing landed in 2022, when Restructuring Costs plunged 85.71%; it then soared 5500.0% in 2023.
• A 5-year view of Restructuring Costs shows it stood at $55.0 million in 2022, then jumped by 45.45% to $80.0 million in 2023, then jumped by 185.0% to $228.0 million in 2024, then sank by 79.82% to $46.0 million in 2025, then soared by 113.04% to $98.0 million in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $98.0 million in Q2 2026, $49.0 million in Q1 2026, and $46.0 million in Q4 2025.